These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15791509)

  • 21. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality.
    Morgan JA; John R; Lee BJ; Oz MC; Naka Y
    Ann Thorac Surg; 2004 Mar; 77(3):859-63. PubMed ID: 14992887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillus left ventricular assist device endocarditis.
    Barbone A; Pini D; Grossi P; Bandera A; Manasse E; Citterio E; Eusebio A; Silvaggio G; Settepani F; Municinò A; Colombo P; Casari E; Ornaghi D; Gronda E; Gallotti R
    Ital Heart J; 2004 Nov; 5(11):876-80. PubMed ID: 15633446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
    Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
    J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative risk factors for mortality after biventricular assist device implantation.
    Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
    J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors predictive of right ventricular failure after left ventricular assist device implantation.
    Drakos SG; Janicki L; Horne BD; Kfoury AG; Reid BB; Clayson S; Horton K; Haddad F; Li DY; Renlund DG; Fisher PW
    Am J Cardiol; 2010 Apr; 105(7):1030-5. PubMed ID: 20346326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.
    Joyce DL; Southard RE; Torre-Amione G; Noon GP; Land GA; Loebe M
    J Heart Lung Transplant; 2005 Dec; 24(12):2054-9. PubMed ID: 16364849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days.
    Martin SI; Wellington L; Stevenson KB; Mangino JE; Sai-Sudhakar CB; Firstenberg MS; Blais D; Sun BC
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):20-3. PubMed ID: 20388700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency versus elective/urgent left ventricular assist device implantation.
    Schmid C; Deng M; Hammel D; Weyand M; Loick HM; Scheld HH
    J Heart Lung Transplant; 1998 Oct; 17(10):1024-8. PubMed ID: 9811412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada.
    Carrier M; Perrault LP; Bouchard D; Pellerin M; Racine N; White M; Pelletier G
    Can J Cardiol; 2004 Apr; 20(5):501-4. PubMed ID: 15100751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart transplant and left ventricular assist device costs.
    Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Right ventricular dysfunction after left ventricular assist device implantation].
    Ríha H; Netuka I; Kotulák T; Malý J; Pind'ák M; Kellovský P; Kopác F; Hodr D; Szarszoi O; Kettner J; Al-Hiti H; Dorazilová Z; Marek T; Skalský I; Pirk J
    Vnitr Lek; 2010 Jan; 56(1):30-6. PubMed ID: 20184109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular immunity impaired among patients on left ventricular assist device for 6 months.
    Kimball PM; Flattery M; McDougan F; Kasirajan V
    Ann Thorac Surg; 2008 May; 85(5):1656-61. PubMed ID: 18442560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.